As swine fever fries China vaccine sales, Boehringer rewrites prescription for recovery
(Reuters Health)

Germany`s Boehringer Ingelheim, the global No. 2 in animal health, is having to rebuild itself in China after a deadly pig disease decimated sales of unrelated mainstay vaccines, bringing write-offs and leaving it facing a three-year slog to recovery.